By Caitlin Dolegowski, Marketing Specialist, LSN
Imagine learning critical components to successful fundraising from key experts and deal-makers in a virtual environment specific to early-stage life science and healthcare. It seems too good to be true until you check out the Digital RESI November lineup. Digital RESI November 16-18 offers attendees three days of panels, workshops and pitch sessions, each of which is designed to enrich the journey of early-stage, life science entrepreneurs with insight into what investors are looking for, how CEOs have found success and learning from other fundraising executives. Panel topics have been created to cover hot industry topics, with panelist recruitment focused on adding valuable content for fundraising attendees. Check out the panelists that will be presenting at this November’s conference below.
Partnering has begun for this conference and there is still time to register to attend!
 |
 |
 |
 |
| Sangeeta Agarawal Co-Founder & CEO Helpsy Health |
Cynthia Cai Venture Partner Viva BioInnovator |
Mylea Charvat Principal & Partner LiquidSMARTS |
Jonathan Cohen CEO 20/20 GeneSystems |
 |
 |
 |
 |
| Ruchi Dana Board Member Dana Group |
Nissim Darvish Senior Managing Director (Israel) OrbiMed Advisors LLC |
Dave Dlesk CEO Embrace Prevention Care |
Keren Etkin Founder TheGerontechnologist |
 |
 |
 |
 |
| Lana Feng Co-Founder & CEO HumaAI Inc |
Dave Fogel Member of Screening & Due Diligence Committees Mass Medical Angels |
Michael Fossel President and Founder Telocyte |
Les Funtleyder Chief Investment Officer TechNik |
 |
 |
 |
 |
| Shruti Gandhi Founder & Managing Partner Array Ventures |
Ernst Geutjes Partner Aglaia Oncology Funds |
Tom Gibbs Director Debiopharm Innovation Fund |
Kimberly Ha Founder & CEO KKH Advisors |
 |
 |
 |
 |
| André Harrell Venture Partner Cancer Fund |
Chihiro Hosoya BD/VC Head, Rx+ Business Accelerator Astellas Rx+ Business Accelerator |
Baudouin Hue Partner Karista |
Rachel Stillman, MBA Senior Associate 7wire Ventures |
 |
 |
 |
 |
| Taha Jangda Partner HealthX Ventures |
Yury Kukushkin Investment Director JDRF T1D Fund |
Pepper Landson CEO Praetego Inc |
Taja Lester Managing Partner Health Equity Capital |
 |
 |
 |
 |
| Justin Leushner Partner Launchit Ventures |
Richard Lipkin Co-Founder, Co-Chair The Catalytic Impact Foundation |
Betsabeh Madani Hermann, MBA Life Science and Healthcare Investor and Advisor |
Andrew Meadow General Partner Health Innovation Capital |
 |
 |
 |
 |
| Andy Merken Partner, Corporate and Securities Co-Chair, Life Sciences Burns & Levinson |
Brian Meshkin Managing Partner Profound Ventures |
Petra Meyer Managing Director – HealthCare Sector Group Lead Golden Seeds |
Christos Monovoukas VP, Global M&A/Business Development Olympus Corporation |
 |
 |
 |
 |
| Alex Morgan Partner Khosla Ventures |
Sasha Naydich Associate Myeloma Investment Fund |
Rohit Pratap Singh Vice President, Investments Xeraya Capital |
Rachel Rea Director of Business Development and Licensing Medtronic |
 |
 |
 |
 |
| Christina Salys Director of New Business Development Intuitive Surgical |
Beth Sanders Founder & CEO LifeBio Inc |
Diana Saraceni Founder, Managing Director Panakes Partners |
Rachel Scherl CEO SPARK Solutions for Growth |
 |
 |
 |
 |
| DJ (Dennis) Schmitt Founder/CEO Neuro20 Technologies |
Bryan Shao K4 Deal Screening Committee Keiretsu Forum |
Xuhui Shao Managing Partner Foothill Ventures |
Patrik Sobocki Investment Manager Life Science Industrifonden |
 |
 |
 |
 |
| Thomas Vogelsong Investor/Life Science Advisor/Director, Deal Flow KYTO Technology and Life Science |
Richard Ward Director, Search and Evaluation, Oncology R&D BD AstraZeneca |
Travis Whitfill Partner Bios Partners |
Thierry Wurch Senior Director Ipsen S.A. |
 |
 |
||
| Tiffany Yu Vice President Equality Asset Management LP |
Lu Zhang Managing Partner Fusion Fund |
Next Phase Newsletter 
Leave a Reply